These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25344601)

  • 1. Discovery and validation of novel expression signature for postcystectomy recurrence in high-risk bladder cancer.
    Mitra AP; Lam LL; Ghadessi M; Erho N; Vergara IA; Alshalalfa M; Buerki C; Haddad Z; Sierocinski T; Triche TJ; Skinner EC; Davicioni E; Daneshmand S; Black PC
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25344601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting individual outcomes after radical cystectomy: an external validation of current nomograms.
    Zaak D; Burger M; Otto W; Bastian PJ; Denzinger S; Stief CG; Buchner H; Hartmann A; Wieland WF; Shariat SF; Fritsche HM
    BJU Int; 2010 Aug; 106(3):342-8. PubMed ID: 20002664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder.
    Nuhn P; May M; Sun M; Fritsche HM; Brookman-May S; Buchner A; Bolenz C; Moritz R; Herrmann E; Burger M; Tilki D; Trojan L; Perrotte P; Haferkamp A; Hohenfellner M; Wieland WF; Müller SC; Karakiewicz PI; Bastian PJ
    Eur Urol; 2012 Jan; 61(1):58-64. PubMed ID: 21840642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External Validation of Bladder Cancer Predictive Nomograms for Recurrence, Cancer-Free Survival and Overall Survival following Radical Cystectomy.
    Brooks M; Godoy G; Sun M; Shariat SF; Amiel GE; Lerner SP
    J Urol; 2016 Feb; 195(2):283-9. PubMed ID: 26343350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort.
    Aziz A; May M; Burger M; Palisaar RJ; Trinh QD; Fritsche HM; Rink M; Chun F; Martini T; Bolenz C; Mayr R; Pycha A; Nuhn P; Stief C; Novotny V; Wirth M; Seitz C; Noldus J; Gilfrich C; Shariat SF; Brookman-May S; Bastian PJ; Denzinger S; Gierth M; Roghmann F;
    Eur Urol; 2014 Jul; 66(1):156-63. PubMed ID: 24388438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor expression of miR-34a-3p is an independent predictor of recurrence in non-muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram.
    Juracek J; Stanik M; Vesela P; Radova L; Dolezel J; Svoboda M; Slaby O
    Urol Oncol; 2019 Mar; 37(3):184.e1-184.e7. PubMed ID: 30446443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder.
    Al-Daghmin A; English S; Kauffman EC; Din R; Khan A; Syed JR; Sztorc J; Mehedint D; Sharif M; Shi Y; Wilding G; Guru KA
    BJU Int; 2014 Aug; 114(2):253-60. PubMed ID: 24119175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
    Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP
    J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
    Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M
    BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel nomograms to predict recurrence and progression in primary non-muscle-invasive bladder cancer: validation of predictive efficacy in comparison with European Organization of Research and Treatment of Cancer scoring system.
    Kim HS; Jeong CW; Kwak C; Kim HH; Ku JH
    World J Urol; 2019 Sep; 37(9):1867-1877. PubMed ID: 30535715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer.
    Wang Y; Zhang L; Wang B; Cheng Y
    Biomed Res Int; 2021; 2021():6699131. PubMed ID: 34337046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomograms predicting response to therapy and outcomes after bladder-preserving trimodality therapy for muscle-invasive bladder cancer.
    Coen JJ; Paly JJ; Niemierko A; Kaufman DS; Heney NM; Spiegel DY; Efstathiou JA; Zietman AL; Shipley WU
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):311-6. PubMed ID: 23474117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer:A population-based study.
    Yang Z; Bai Y; Liu M; Hu X; Han P
    Cancer Med; 2020 Dec; 9(24):9303-9314. PubMed ID: 33063464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Lymph Node Metastasis in Patients with Bladder Cancer Using Whole Transcriptome Gene Expression Signatures.
    Seiler R; Lam LL; Erho N; Takhar M; Mitra AP; Buerki C; Davicioni E; Skinner EC; Daneshmand S; Black PC
    J Urol; 2016 Oct; 196(4):1036-41. PubMed ID: 27105761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors.
    Honma I; Masumori N; Sato E; Takayanagi A; Takahashi A; Itoh N; Tamagawa M; Sato MA; Tsukamoto T
    Urology; 2004 Oct; 64(4):744-8. PubMed ID: 15491713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer.
    Song Y; Jin D; Chen J; Luo Z; Chen G; Yang Y; Liu X
    Aging (Albany NY); 2020 Jun; 12(12):12051-12073. PubMed ID: 32579540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a nine-gene panel as a prognostic indicator for recurrence with muscle-invasive bladder cancer.
    Han Y; Zheng Q; Tian Y; Ji Z; Ye H
    J Surg Oncol; 2019 Jun; 119(8):1145-1154. PubMed ID: 30887516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative nomogram for invasive bladder cancer: does it really work? A multicenter cohort study.
    Bassi PF; Bongiovanni L; Racioppi M; Volpe A; D'Agostino D; Gardi M; ;
    Urol Oncol; 2011; 29(6):698-702. PubMed ID: 19959381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer.
    Chang SS
    J Urol; 2015 Aug; 194(2):334. PubMed ID: 26195361
    [No Abstract]   [Full Text] [Related]  

  • 20. Nomogram for predicting survival of postcystectomy recurrent urothelial carcinoma of the bladder.
    Nakagawa T; Taguchi S; Uemura Y; Kanatani A; Ikeda M; Matsumoto A; Yoshida K; Kawai T; Nagata M; Yamada D; Komemushi Y; Suzuki M; Enomoto Y; Nishimatsu H; Ishikawa A; Nagase Y; Kondo Y; Tanaka Y; Okaneya T; Hirano Y; Shinohara M; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
    Urol Oncol; 2017 Jul; 35(7):457.e15-457.e21. PubMed ID: 28110856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.